Triple

T22880688
Position Surface form Disambiguated ID Type / Status
Subject Tommy Thompson E567457 entity
Predicate notableWork P4 FINISHED
Object Medicare Part D implementation — NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medicare Part D implementation | Statement: [Tommy Thompson, notableWork, Medicare Part D implementation]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Medicare Part D implementation
Context triple: [Tommy Thompson, notableWork, Medicare Part D implementation]
  • A. Medicare Part D chosen
    Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
  • B. Special Enrollment Periods for Medicare Part D
    Special Enrollment Periods for Medicare Part D are limited-time windows outside the standard enrollment period during which eligible individuals can sign up for or change their Medicare prescription drug coverage due to specific life events or circumstances.
  • C. Medicare Prescription Drug, Improvement, and Modernization Act of 2003
    The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
  • D. Medicaid Drug Rebate Program
    The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
  • E. 340B Drug Pricing Program
    The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2458a92ec81908fc1cd5f6407d2ab completed April 17, 2026, 2:36 p.m.
NER Named-entity recognition batch_69f17f5c1ed88190aeac131c5aff6102 completed April 29, 2026, 3:47 a.m.
Created at: April 17, 2026, 3:39 p.m.